Bone Health and Natural Products- An Insight
- PMID: 30283334
- PMCID: PMC6157411
- DOI: 10.3389/fphar.2018.00981
Bone Health and Natural Products- An Insight
Abstract
Bone metabolism involves a complex balance between matrix deposition, mineralization, and resorption. Numerous evidences have revealed that dietary components and phytoconstituents can influence these processes, through inhibition of bone resorption, thus exhibiting beneficial effects on the skeleton. Various traditional herbal formulae in ayurvedic and Chinese medicine have shown demonstrable benefits in pharmacological models of osteoporosis. The present review discusses normal bone metabolism and disorders caused by bone disruption, with particular reference to osteoporosis and current therapeutic treatment. Furthermore the effects of constituents from natural products on bone tissue are explained, with relevant evidences of efficacy in various experimental models.
Keywords: bone disorders; osteoblast; osteoclast; osteoporosis; phytochemicals.
Figures
Similar articles
-
Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health.Phytother Res. 2007 Feb;21(2):99-112. doi: 10.1002/ptr.2030. Phytother Res. 2007. PMID: 17106868 Review.
-
Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.J Ethnopharmacol. 2016 Aug 2;189:61-80. doi: 10.1016/j.jep.2016.05.025. Epub 2016 May 11. J Ethnopharmacol. 2016. PMID: 27180315 Review.
-
Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs.J Ethnopharmacol. 2014 Sep 29;155(3):1401-16. doi: 10.1016/j.jep.2014.07.058. Epub 2014 Aug 7. J Ethnopharmacol. 2014. PMID: 25109459 Review.
-
Evolving Roles of Natural Terpenoids From Traditional Chinese Medicine in the Treatment of Osteoporosis.Front Endocrinol (Lausanne). 2022 May 16;13:901545. doi: 10.3389/fendo.2022.901545. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35651977 Free PMC article. Review.
-
Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.Curr Drug Targets. 2020;21(16):1640-1651. doi: 10.2174/1389450121666200731173522. Curr Drug Targets. 2020. PMID: 32735518 Review.
Cited by
-
Integrating network pharmacology, IPA, and molecular docking to reveal the anti-osteoporosis effects of EA and EB via the FAK pathway.Front Pharmacol. 2025 Jul 2;16:1532665. doi: 10.3389/fphar.2025.1532665. eCollection 2025. Front Pharmacol. 2025. PMID: 40672377 Free PMC article.
-
Anacardic acid-mediated regulation of osteoblast differentiation involves mitigation of inflammasome activation pathways.Mol Cell Biochem. 2021 Feb;476(2):819-829. doi: 10.1007/s11010-020-03947-9. Epub 2020 Oct 22. Mol Cell Biochem. 2021. PMID: 33090336
-
Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss.Front Pharmacol. 2022 Nov 2;13:1032866. doi: 10.3389/fphar.2022.1032866. eCollection 2022. Front Pharmacol. 2022. PMID: 36408260 Free PMC article.
-
In Vitro Antiosteoporosis Activity and Hepatotoxicity Evaluation in Zebrafish Larvae of Bark Extracts of Prunus jamasakura Medicinal Plant.Evid Based Complement Alternat Med. 2020 Sep 15;2020:8582318. doi: 10.1155/2020/8582318. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33029177 Free PMC article.
-
The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis.Front Endocrinol (Lausanne). 2021 Nov 12;12:744647. doi: 10.3389/fendo.2021.744647. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34867788 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources